{
  "id": "8236ce573f12a79b",
  "title": "STAT+: Pharmalittle: We\u2019re reading about pharma lobbying, an FDA gene-editing pathway, and more",
  "description": "The pharmaceutical industry, long one of the most powerful lobbies in Washington, is spending more than ever to influence the nation\u2019s capital",
  "content": "The pharmaceutical industry, long one of the most powerful lobbies in Washington, is spending more than ever to influence the nation\u2019s capital",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/26/pharma-lobbying-novo-genes-fda-patents/?utm_campaign=rss",
  "published_at": "2026-01-26T14:05:25+00:00",
  "fetched_at": "2026-01-27T00:25:22.667063+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about pharma lobbying, an FDA gene-editing pathway, and more",
    "description": "The pharmaceutical industry, long one of the most powerful lobbies in Washington, is spending more than ever to influence the nation\u2019s capital",
    "url": "https://www.statnews.com/pharmalot/2026/01/26/pharma-lobbying-novo-genes-fda-patents/?utm_campaign=rss",
    "published": "2026-01-26T14:05:25+00:00",
    "source": "STAT"
  }
}